TOKYO -- The Japanese biotech startup Genex has developed software that improves the efficiency of genetic testing for intractable mitochondrial diseases.
Health Care
Tokyo startup offers efficient tests for mitochondrial diseases
Genex's software identifies relationships between genetic mutations and disorders
Genex's software can analyze the relevance of multiple mutations in patients with mitochondrial diseases. (Photo by Akiyoshi Inoue)
Read Next
Latest on Health Care
